Thymalfasin is a chemically synthesized version of thymosin alpha 1 that is identical to human thymosin alpha 1. Thymosin alpha 1 is an acetylated polypeptide. Thymosin alpha 1 is now approved in 35 developing countries for the treatment of Hepatitis B and C. It is also used to boost the immune response in the treatment of other diseases.
⑴慢性乙型肝炎(简称乙肝)。本品是用来治疗那些18岁或以上的慢性乙型肝炎患者,患者的肝病有代偿性,和有乙型肝炎病毒复制(血清HBV-DNA阳性),在那些血清乙肝表面抗原(HBsAg)阳性最少6个月,且有ALT升高的患者所做的研究显示,本品治疗可以产生病毒性缓解(血清HBV-DNA失去)和ALT水平复常,在一些做出应答的患者,本品治疗可除去血清表面抗原。本品与α-干扰素联用时可能比单用本品或单用干扰素增加应答率。
⑵作为免疫损害患者的疫苗增强剂。免疫系统功能受到抑制者,包括接受慢性血液透析和老年病患者,本品增强患者对病毒性疫苗,例如流感疫苗或乙肝疫苗的免疫应答。血液透析患者在接种流感疫苗后,应用本品作为佐剂者有65%患者产生抗流感病毒抗体,滴度水平增加4倍以上,安慰剂组只有24%患者做出此反应。
Beijing Friendship Hospital,Capital Medical University, Beijing, China
Peking Union Medical College Hospital, Beijing, China
Beijing Friendship Hospital, Capital medical University, Beijing, Xicheng Dis, China
The Second Affiliated Hospital of SchoowUniversity, Suzhou, China
The Miriam Hospital, Providence, Rhode Island, United States
Clinical Research Consultants, Kansas City, Kansas, United States
Hangzhou Cancer Hospital, Hangzhou, Zhejiang, China
Zhongshan Hospital, Shanghai, Shanghai, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.